Octreotide Microsphere-Based Arterial Embolization for Treating Obesity
OwnerFuad Nurili, Omer Arasinventors
Life of this patent
Estimating the term…
Abstract
This invention provides a method for causing weight loss in a subject comprising introducing biodegradable microspheres into one or more of the subject's gastric arteries, wherein the microspheres (i) have a d90 value from 40 μm to 500 μm; (ii) comprise polylactic acid (PLA) and/or polylactic co-glycolic acid (PLGA); (iii) carry a therapeutically effective amount of pharmaceutical octreotide; (iv) embolize gastric arterial vessels supplied by the one or more arteries into which they are introduced; and (v) release octreotide during embolization.
Claims14
A method for causing weight loss in a subject comprising introducing biodegradable microspheres into one or more of the subject's gastric arteries, wherein the microspheres (i) have a d90 value from 40 μm to 500 μm;
- (ii) comprise polylactic acid (PLA) and/or polylactic co-glycolic acid (PLGA);
- (iii) carry a therapeutically effective amount of pharmaceutical octreotide;
- (iv) embolize gastric arterial vessels supplied by the one or more arteries into which they are introduced;
- and (v) release octreotide during embolization.
A method for causing weight loss in a human subject having a BMI of 40 or higher comprising introducing biodegradable microspheres into the subject's left gastric artery, wherein the microspheres (i) have a d90 value from 70 μm to 150 μm;
- (ii) comprise PLA and PLGA at a PLA:PLGA molar ratio of 45:55;
- (iii) carry from 10 mg to 20 mg of pharmaceutical octreotide;
- (iv) embolize gastric arterial vessels supplied by the left gastric artery;
- and (v) release octreotide during embolization.
Dependencies are inferred from the claim text.